Lymphoma Drug Failure Frustrates Experts
May 1st, 2007 By LAURAN NEERGAARD , AP Medical Writer(AP) -- Only a fraction of patients with hard-to-treat lymphoma ever try two breakthrough "smart-bomb" drugs that bring radiation straight to cancerous cells - with just two shots a week apart, not the usual months of care. The marketing failure has a manufacturer trying to sell off one of the drugs, and increasingly frustrated specialists worry it will jeopardize attempts to expand this promising new field to fight other cancers, too.
Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .
Similar stories from PHYSorg:
New treatment shows promise against recurrent gynecologic cancers
Apr 21, 2009 |
not rated yet |
0
New therapies to treat breast, lymph cancer: studies
Jun 01, 2009 |
not rated yet |
1
Anti-inflammatory drugs may defeat a treatment-resistant type of cancer
Jun 24, 2009 |
not rated yet |
0
New targeted approach to light-activated cancer drugs
Nov 08, 2007 |
4 / 5 (1) |
0
Cognitive behavior therapy helps older adults with anxiety reduce worry, improve mental health
Apr 07, 2009 |
5 / 5 (1) |
0
